Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.
about
ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistanceThe emerging molecular machinery and therapeutic targets of metastasisNormal fibroblasts induce E-cadherin loss and increase lymph node metastasis in gastric cancerAberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLCBioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerNotch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH.High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patientsThe role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective.1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment.Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression.Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma.The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells.Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator.Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition.Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications.CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.Prospects for new lung cancer treatments that target EMT signaling.The zinc finger E-box-binding homeobox 1 (Zeb1) promotes the conversion of mouse fibroblasts into functional neurons.FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1.
P2860
Q27015111-01C54E1B-A8E1-42A4-BBF7-C47E5B53E7EDQ27022207-4AA5C93D-B369-4EF3-9AE0-6C5FB5F39B6EQ27332390-9FB91F24-F584-4B62-BC54-298667DA373BQ34183784-88073797-E6AC-4CF3-A1D0-2164DCF6FD1EQ34295621-C15ABE4B-2256-4A79-AE87-6AAC18BC2F4FQ34712645-2609F091-4CAB-46F9-93B0-2EDF6BC922FAQ35497226-48BCF2D8-6E35-4790-9945-8B8F332D3456Q35632310-2BFD0542-C999-4EEC-8605-91D4F1ED6A2FQ37123982-4570AB5C-99A5-4146-9E8F-62B6CC754AD5Q37420597-480675FA-B5C4-4A1B-A68D-BE4478F593EFQ37476178-A8D847B6-FFB3-4B72-969F-9D2256D88670Q37507345-4BE4C997-F4AD-41C2-8271-47763A072C47Q37666880-F2C9CC9A-9CD2-4022-AF67-002963E412D8Q37728993-FD10ADBD-6C79-451F-9F42-D0B104D91A02Q38206587-A94D4696-D279-45E7-998C-F4CA47012358Q38366840-25ACEEE6-6E8E-4C43-B8E1-4BB8F635F2E2Q38968841-604C9FBF-9237-41FB-BE62-7567EA767497Q41390229-3F10BE27-3227-4A97-9A7A-9DC07F245E2BQ41676866-F36B448C-1E34-4D9B-B933-221ECB91AE25Q41789947-3D05053E-F6F8-4D73-8CE2-242839EBE17FQ47099877-F6EA79E0-0691-494D-B024-82A997F313B8Q47138387-3C812CA6-8756-4DAD-B81F-825EBA88A15CQ47380086-2AA4BC15-34C0-481C-8681-95FDEC0F5AC3Q48271468-DC551930-98F8-489C-9A26-67F84CC65A04Q50438221-1E27A27A-FCA8-4770-8106-7822D411A49CQ51675463-81475F0A-951E-452E-B2FD-910AF155ED00Q55100090-1044D93E-073F-4817-82B9-DD93AA0D383C
P2860
Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of ZEB1 reverses EM ...... lung adenocarcinoma cell line.
@en
Inhibition of ZEB1 reverses EM ...... lung adenocarcinoma cell line.
@nl
type
label
Inhibition of ZEB1 reverses EM ...... lung adenocarcinoma cell line.
@en
Inhibition of ZEB1 reverses EM ...... lung adenocarcinoma cell line.
@nl
prefLabel
Inhibition of ZEB1 reverses EM ...... lung adenocarcinoma cell line.
@en
Inhibition of ZEB1 reverses EM ...... lung adenocarcinoma cell line.
@nl
P2093
P2860
P356
P1476
Inhibition of ZEB1 reverses EM ...... lung adenocarcinoma cell line.
@en
P2093
Haizhu Song
Longbang Chen
Yitian Chen
P2860
P304
P356
10.1002/JCB.24481
P577
2013-06-01T00:00:00Z